Journal of Rheumatic Diseases

Cited by CrossRef (21)

  1. Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis. Z Rheumatol 2023;82:408
    https://doi.org/10.1007/s00393-021-01119-8
  2. Jung Hee Koh, Yusun Lee, Hyoun-Ah Kim, Jinhyun Kim, Kichul Shin. Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry. Therapeutic Advances in Musculoskeletal 2022;14
    https://doi.org/10.1177/1759720X221096363
  3. Seulkee Lee, Seonyoung Kang, Hyungjin Kim, Jaejoon Lee, Min-Ji Kim, Hoon-Suk Cha. Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy. Arthritis Res Ther 2024;26
    https://doi.org/10.1186/s13075-024-03320-x
  4. Hyoun-Ah Kim, So Young Park, Kichul Shin. Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry. J Rheum Dis 2022;29:215
    https://doi.org/10.4078/jrd.22.0005
  5. Oh Chan Kwon, Min-Chan Park. Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis. Yonsei Med J 2023;64:697
    https://doi.org/10.3349/ymj.2023.0151
  6. Young Ho Lee, Gwan Gyu Song. Association between the functional FCGR3AF158V and FCGR2AR131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta‐analysis. Int J of Rheum Dis 2023;26:1295
    https://doi.org/10.1111/1756-185X.14719
  7. Jisoo Lee, Yoon-Kyoung Sung, Myeung-Su Lee, Han Joo Baek. The Korean College of Rheumatology: 40 Years of Public Health Influence. J Rheum Dis 2022;29:75
    https://doi.org/10.4078/jrd.2022.29.2.75
  8. Young Ho Lee, Gwan Gyu Song. Associations between the interleukin-6 rs1800795 G/C and interleukin-6 receptor rs12083537 A/G polymorphisms and response to disease-modifying antirheumatic drugs in rheumatoid arthritis: A meta-analysis. International Immunopharmacology 2022;112:109184
    https://doi.org/10.1016/j.intimp.2022.109184
  9. Young Ho Lee, Gwan Gyu Song. Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2023;82:696
    https://doi.org/10.1007/s00393-022-01290-6
  10. Soo Min Ahn, Young Bin Joo, Yun Jin Kim, So-Young Bang, Hye-Soon Lee. Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases. J Korean Med Sci 2023;38
    https://doi.org/10.3346/jkms.2023.38.e172
  11. Ji-Won Kim, Eunyoung A. Lee, Hyoun-Ah Kim, Chang-Hee Suh, Ju-Yang Jung. Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry. BioDrugs 2022;36:411
    https://doi.org/10.1007/s40259-022-00524-y
  12. Sun-Kyung Lee, Kichul Shin, Ju-Yang Jung, Chang-Hee Suh, Ji-Won Kim, Hyoun-Ah Kim. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study. BioDrugs 2023
    https://doi.org/10.1007/s40259-023-00578-6
  13. Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee, Taeeun Kim, Kichul Shin. The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2023;15
    https://doi.org/10.1177/1759720X231201714
  14. Hyoun-Ah Kim, Eunyoung Lee, So Young Park, Shin-Seok Lee, Kichul Shin. Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy. J Korean Med Sci 2022;37
    https://doi.org/10.3346/jkms.2022.37.e253
  15. Jun Won Park, Ju Yeon Kim, Min Jung Kim, Yoo Kyoung Lim, Hyoun-Ah Kim, Jin Hyun Kim, Kichul Shin. Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry. Front. Med. 2024;11
    https://doi.org/10.3389/fmed.2024.1418243
  16. M. Kwon, C. I. Joung, H. Shin, C. C. Lee, Y. S. Song, Y. J. Lee, S. Kang, J. Y. Kim, S. Lee. Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-52822-w
  17. Min Jung Kim, Sun-Kyung Lee, Sohee Oh, Hyoun-Ah Kim, Yong-Beom Park, Shin-Seok Lee, Kichul Shin. Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry. Rheumatol Ther 2022;9:1143
    https://doi.org/10.1007/s40744-022-00467-4
  18. Young Ho Lee. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology 2022;107:537
    https://doi.org/10.1159/000525627
  19. Seong-Ryul Kwon, Tae-Hwan Kim, Tae-Jong Kim, Won Park, Seung Cheol Shim. The Epidemiology and Treatment of Ankylosing Spondylitis in Korea. J Rheum Dis 2022;29:193
    https://doi.org/10.4078/jrd.22.0023
  20. Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2024;16
    https://doi.org/10.1177/1759720X231218098
  21. Ju-Yang Jung, Eunyoung Lee, Ji-Won Kim, Chang-Hee Suh, Kichul Shin, Jinhyun Kim, Hyoun-Ah Kim. Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry. Arthritis Res Ther 2023;25
    https://doi.org/10.1186/s13075-023-03165-w